BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190710
DTEND;VALUE=DATE:20190712
DTSTAMP:20260514T232811
CREATED:20190522T082202Z
LAST-MODIFIED:20190522T082202Z
UID:20825-1562716800-1562889599@www.pharmajournalist.com
SUMMARY:Clinical Operations in Oncology Trials to East Coast 2019
DESCRIPTION:Arena International is excited to announce the return of the 7th Annual Clinical Operations in Oncology Trials to the East Coast on July 10th-July 11th 2019. \nAs one of the only oncology operationally focused events in the East Coast\, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage East Coast physicians and patients. \nThe event will be led by a myriad of industry specialists from the East Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion\, spotlight Q&As\, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market. \nWhile maintaining the primary focus of its previous years\, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry\, and provide insight into the latest technological and therapeutic solutions. \nThis July prepare to hear from  industry leading oncologists about accurate abidance to ICH E8 guidelines\, effective oversight strategies\, efficient trial designs and data management solutions. As pharmaceutical companies shift to conducting immuno-oncology trials and look towards how AI\, data analytics and cutting edge technology can aid with early diagnosis\, take this opportunity to stay updated with industry trends and showcase your innovative solutions to key decision makers. \nWe hope to see you in July\, make sure to register your place today!
URL:https://www.pharmajournalist.com/event/clinical-operations-in-oncology-trials-to-east-coast-2019/
LOCATION:Boston\, Massachusetts
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190716
DTEND;VALUE=DATE:20190719
DTSTAMP:20260514T232811
CREATED:20190204T112557Z
LAST-MODIFIED:20190204T113033Z
UID:19372-1563235200-1563494399@www.pharmajournalist.com
SUMMARY:Indian Pharma Expo & Business Excellence Award 2019
DESCRIPTION:CIMS Medica presents the 8th edition of Indian Pharma Expo (IPE)\, scheduled to be held on 16th-18th July\, 2019 at Hall No. 12-A\, Pragati Maidan\, New Delhi. \n \nPrevious year IPE set another successful milestone with presence of visitors from all parts of India and provided a common platform for promising sellers and potential buyers from Pharmaceutical and Healthcare Industries. With IPE\, the benefits are bound to get augmented with presence of eminent personalities from various sectors of Pharma\, non-pharma and healthcare industries. It will gather representation from various companies like Pharmaceutical manufacturers & marketers\, packaging solution providers\, machinery solution providers\, franchise companies and many more under one roof. \nThe 3-day expo will bring together eminent personalities from various sectors of Pharmaceutical\, non-pharma and healthcare industries. IPE 2019 is one stop juncture to all those who are planning to expand their business through various channels of franchise and distribution; as well as wholesalers and hospital purchase personnel who seek to buy bulk products on concessional rates. \nThis year IPE will be one point contact to exchange the business opportunities for National and International Pharmaceutical Companies. This event will prove to be a business expansion tool to many small-medium-major players in Pharmaceutical Industry.
URL:https://www.pharmajournalist.com/event/indian-pharma-expo-business-excellence-award-2019/
LOCATION:Hall no. 12-A\, Pragati Maidan\, New Delhi\, Delhi\, India
ORGANIZER;CN="CIMS Medica India Pvt Ltd":MAILTO:ipe@cims.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190716
DTEND;VALUE=DATE:20190719
DTSTAMP:20260514T232811
CREATED:20190424T121423Z
LAST-MODIFIED:20190424T121423Z
UID:20441-1563235200-1563494399@www.pharmajournalist.com
SUMMARY:PREDiCT: Tumor Models Boston
DESCRIPTION:The 7th Annual PREDiCT: Tumor Models Boston summit will explore robust preclinical strategies utilizing current and emerging model systems to overcome core challenges across the early stages of cancer drug development. Presentations will span preclinical strategies validating new anticancer drugs\, assessing therapeutic index and identifying surrogate markers of tumor progression. \n \nPlug into a network of preclinical and translational scientists seeking to share methods for the rational design of combinations\, patient stratification and identify new strategies to model metastasis\, resistance and sensitivity. \nWhy attend PREDiCT : Tumor Models Boston ? \n\n35+ Preclinical & Translational Oncology Heads\, each pioneering the further development and application of experimental models\, will be sharing the latest insights on the impact of their work.\n100+ senior level scientists from Sanofi\, Kleo Pharmaceuticals\, NIH\, Dicerna\, Pfizer\, Crown Bioscience\, The Jackson Laboratory\, Eisai and many more are set to review the comparative cost-per-data point of next generation models alongside classical model-systems.\nWe’ll explore how classical and emerging models are evolving efficacy determination\, biomarker discovery and combination therapies\, allowing you to further develop your research and gain the best insight of the industry.\n\nDownload the full event guide to find out more! \nTo learn more about this event\, and to register online\, visit https://tumor-models.com/
URL:https://www.pharmajournalist.com/event/predict-tumor-models-boston/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190716
DTEND;VALUE=DATE:20190719
DTSTAMP:20260514T232811
CREATED:20190617T102853Z
LAST-MODIFIED:20190617T102853Z
UID:21229-1563235200-1563494399@www.pharmajournalist.com
SUMMARY:IMPACCT: mHealth in Clinical Trials Summit
DESCRIPTION:The IMPACCT: mHealth in Clinical Trials series provides a dedicated forum for industry leaders in clinical and digital innovation to share data\, best practice and game-changing approaches on how to transform the clinical research paradigm with digital technology and achieve true patient-centricity. \nJoin your peers and leading experts in this space for a collaborative discussion aiming to tackle key implementation challenges and accelerate the successful incorporation of innovative digital strategies in clinical R&D\, to enhance patient experience and outcomes. \nIndustry leaders already confirmed include Novartis\, AbbVie\, the DiMe Society\, Verily & many others.
URL:https://www.pharmajournalist.com/event/impacct-mhealth-in-clinical-trials-summit/
LOCATION:The Westin Copley Place Boston\, 10 Huntington Ave\, Boston\, MA\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190723
DTEND;VALUE=DATE:20190726
DTSTAMP:20260514T232811
CREATED:20190404T071545Z
LAST-MODIFIED:20190404T071545Z
UID:20177-1563840000-1564099199@www.pharmajournalist.com
SUMMARY:2nd Neuropsychiatric Drug Development Summit
DESCRIPTION:THE INDUSTRY’S DEFINITIVE MEETING TO ADVANCE THE DEVELOPMENT OF CLINICALLY TRANSFORMATIVE NEUROPSYCHIATRIC DRUGS \n \nWith the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available\, the development of the next generation of neuropsychiatric drugs is essential. \nThe abundance of excitement and scientific progress in the field – especially with the recent approval of esketamine – will be captured at the Neuropsychiatric Drug Development summit\, in Boston on July 23 – 25\, 2019. \nBuilt with thought-leaders at Sage Therapeutics\, Johnson & Johnson and Lundbeck\, the 2nd Annual NPD summit will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs. \nDedicated to overcoming challenges in neuropsychiatric drug development\, this comprehensive discussion and networking forum will cover: \n\nReviewing the current clinical landscape to share learned lessons\, predict potential success and identify future opportunities\nDetermine what we can expect from neuropsychiatric preclinical models to better predict clinical efficacy\nUtilize what we know from the clinical to improve our use of translational strategies\nDiscuss the potential for digital therapeutics to transform the success of efficacious pharmaceuticals\nReview symptomatic focused drug development to identify the benefits and impact future regulation\nEvaluate the potential for different neuropsychiatric targets by improving our understanding of neuropsychiatric biology\nImproving our understanding of the role of genetics in neuropsychiatry and debating the future of precision medicine for neuropsychiatric disorders\n\nJoin your peers at NPD to be part of the cross-industry discussion on latest developments\, insights and science to elevate clinically effective neuropsychiatric therapeutic pipelines \nTo learn more about this event\, visit https://ter.li/belugv
URL:https://www.pharmajournalist.com/event/2nd-neuropsychiatric-drug-development-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR